We are live on ! Find out more
AFJKR

Aimei Health Technology Co Right
AFJKR

15 hedge funds and large institutions have $1.73M invested in Aimei Health Technology Co Right in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 1215 (+3)

5% more capital invested

Capital invested by funds: $1.64M → $1.73M (+$89.7K)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
6
Closed
Calls
Puts
Net Calls
Net Calls Change

AFJKR Hedge Fund Activity: Q4 2025 in Review

15 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Right (AFJKR) for Q4 2025, worth a combined $1.73M — up 5.5% from $1.64M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AFJKR positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Highbridge Capital Management, adding an estimated $96.6K. The largest seller was Toronto Dominion Bank, cutting an estimated $239K.

  • 15 institutional investors held Aimei Health Technology Co Right (AFJKR) as of Q4 2025, up from 12 in Q3 2025.
  • Funds reported $1.73M of Aimei Health Technology Co Right stock for Q4 2025, up 5.5% quarter-over-quarter.
  • 3 funds opened new Aimei Health Technology Co Right positions in Q4 2025 and 0 closed out, a net change of +3 holders.
  • The largest Aimei Health Technology Co Right buyer in Q4 2025 was Highbridge Capital Management, an estimated $96.6K added.
  • The largest Aimei Health Technology Co Right seller in Q4 2025 was Toronto Dominion Bank, an estimated $239K sold.

Based on aggregated 13F filings for Q4 2025.